Clovis Oncology Inc. (CLVS) Gained 18.75% or 2.18 To Price $13.81 On Thursday


Clovis Oncology Inc. (CLVS) gained 18.75% or 2.18 to $13.81. It is about 3.64 million shares traded, which is 123.42% compare to the average total volume 2.95 million. The market cap of CLVS is $727.09 million. The year to date change is -63.65%. The 52 week price range is from $11.5 to $76.18. Price of CLVS have changed -38.07% during last week. It have changed -62.89% over last month, -74.52% over last 3 months, -74.33% over last 6 months and -84.36% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CLVS is 29.94. It is 116.80% above current price. The 200-day Moving Averages for CLVS is 45.10. It is 226.57% above current price. The 52-week High is 76.18. It is 451.63% from the current price. The 52-week Low is 11.5. It is -16.73% from current price.

There are some statistics of CLVS. It is has market cap $727.09 million. The share outstanding is 52.65 million. The average volume is 2.95 million. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CLVS is -88.83%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CLVS is -32.07%.


Tags:

Share this post